Mode
Text Size
Log in / Sign up
N/A N=105 Randomized Treatment

An Interactive Text-Message Based Brief Intervention to Reduce Substance-Impaired Driving Among College Students

Alcohol-Impaired Driving

Enrolled (actual)
105
Serious AEs
Results posted
Aug 2025
Primary outcome: Primary: Change in Number of Times Driving After Using Substances — 22.43; 26.50; 26.00 Driving Events

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Personalized feedback (Behavioral); Personalized feedback and text messages (Behavioral); Information Only (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Western Kentucky University
Primary completion
Apr 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Number of Times Driving After Using Substances
22.43; 26.50; 26.00

Summary

Substance-Impaired Driving among college students remains a significant public health concern and may be the single riskiest substance-related outcome among young adults. Brief Interventions (BIs) have been shown to reduce alcohol-impaired driving among college students, but are not often implemented - despite their demonstrated efficacy - because it is not economically feasible for universities to hire and train staff to deliver in-person BIs to all college substance users. Very few college students seek out substance prevention or treatment services available on campus or in the surrounding community. Innovative ways of delivering BIs to this at-risk population in a manner that is both effective and economically feasible have to be developed. The present study will be the first to examine whether a text-messaging-based substance-impaired driving BI significantly decreases substance-impaired driving among colleges substance users compared to an informational control. Participants will be 150 college students who endorse driving after substance use (alcohol, drugs, and/or combined alcohol/drugs) at least twice in the past 3 months. After completing baseline measures, participants will be randomly assigned to receive either: a) substance use information, b) a substance-impaired driving personalized feedback intervention, or c) a substance-impaired driving personalized feedback intervention plus interactive text messages. Participants will complete outcome measures 3, 6, and 12 months post-intervention. Repeated measures mixed modeling analyses will be used to determine whether the intervention significantly reduces substance-impaired driving over time. The project has two specific aims: 1) to evaluate a text based substance-impaired driving intervention in a randomized clinical trial, and 2) to determine whether the use of interactive text-messages sustains intervention effects over time. This study is innovative because it utilizes cutting-edge technology to deliver the entire intervention, enabling the study to reach a large number of students in a short time period at a low cost. The study is significant because it will contribute substantially to the substance-impaired driving literature by identifying an intervention that can decrease substance-impaired driving among this high-risk population. Additionally, this study will add to the newly emerging technology-based intervention literature.

Eligibility Criteria

Inclusion Criteria

  • Age 18 or older
  • Currently enrolled (full or part-time) in college
  • Ability to speak, read, and write in English
  • Reports driving after drinking two or more drinks prior to driving at least three times in the past three months AND/OR reports driving after using marijuana or any other substance prior to driving at least three times in the past three months
  • Reports having access to a motor vehicle, a valid driver's license, and plans to drive a vehicle in the next 3 months
  • Reports access to a cell phone and willingness to read intervention material and exchange 3 texts post intervention with the study administrator
  • Reports a valid email address

Exclusion Criteria

  • Currently in treatment for substance use or abuse
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03496129). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search